CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 62 filers reported holding CIDARA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $249,000 | +12.7% | 94,143 | 0.0% | 0.47% | -5.0% |
| Q4 2018 | $221,000 | +10.0% | 94,143 | +105.8% | 0.50% | +71.5% |
| Q3 2018 | $201,000 | -15.5% | 45,752 | 0.0% | 0.29% | -17.1% |
| Q2 2018 | $238,000 | +30.1% | 45,752 | 0.0% | 0.35% | +5.4% |
| Q1 2018 | $183,000 | -55.9% | 45,752 | -24.9% | 0.33% | -41.2% |
| Q4 2017 | $415,000 | +28.1% | 60,961 | +52.4% | 0.57% | +27.5% |
| Q3 2017 | $324,000 | -4.1% | 40,000 | -11.1% | 0.44% | -10.7% |
| Q2 2017 | $338,000 | – | 45,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |